Bimatoprost recalls

The FDA has published 6 recalls involving Bimatoprost since 2017. The latest was reported on 30 Apr 2025. Most were for potency & assay. Lupin Pharmaceuticals has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls6since 2017

Last 12 months0reported

Class I00% of total

Ongoing0latest 30 Apr 2025

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 0 0Feb 0 1 0May 0 0 0Aug 0 0 0Nov 0 0 0Feb 0 0 0May 0 0 0Aug 0 0

Severity split

Class I 0 0%Class II 1 17%Class III 5 83%

Why bimatoprost is recalled

Companies

Brands

Lumigan233%
Bimatoprost117%

By year

2025117%
2020117%
2019233%
2017233%

All bimatoprost recalls, newest first

6 total

Reported	Class	Recall	Company	Reason	Where
30 Apr 2025Drug	CLASS II	Bimatoprost powder, Bulk Ingredient, a) recalled by Medisca	Medisca	Manufacturing (CGMP) Deviations	Nationwide
8 Jan 2020Drug	CLASS III	Bimatoprost Ophthalmic Solution, 0.03%, For Use recalled	Lupin Pharmaceuticals	Potency & Assay	Nationwide
6 Nov 2019Drug	CLASS III	Bimatoprost Ophthalmic Solution recalled by SandozBimatoprost	Sandoz	Packaging Defects	Nationwide
13 Feb 2019Drug	CLASS III	Bimatoprost Ophthalmic Solution recalled by Lupin Pharmaceuticals	Lupin Pharmaceuticals	Potency & Assay	Nationwide
22 Nov 2017Drug	CLASS III	Lumigan (bimatoprost ophthalmic solution) recalled by Allergan SalesLumigan	Allergan Sales	Potency & Assay	Nationwide
19 Apr 2017Drug	CLASS III	Lumigan (bimatoprost ophthalmic solution) recalled by Allergan SalesLumigan	Allergan Sales	Potency & Assay	Nationwide

Should you stop taking Bimatoprost?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.